• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝 Crtc2 通过 miR-34a-Fgf21 轴控制全身能量代谢。

Hepatic Crtc2 controls whole body energy metabolism via a miR-34a-Fgf21 axis.

机构信息

Division of Life Sciences, Korea University, 145 Anam-Ro, Seongbuk-Gu, Seoul, 02841, Korea.

出版信息

Nat Commun. 2017 Nov 30;8(1):1878. doi: 10.1038/s41467-017-01878-6.

DOI:10.1038/s41467-017-01878-6
PMID:29192248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5709393/
Abstract

Liver plays a crucial role in controlling energy homeostasis in mammals, although the exact mechanism by which it influences other peripheral tissues has yet to be addressed. Here we show that Creb regulates transcriptional co-activator (Crtc) 2 is a major regulator of whole-body energy metabolism. Crtc2 liver-specific knockout lowers blood glucose levels with improved glucose and insulin tolerance. Liver-specific knockout mice display increased energy expenditure with smaller lipid droplets in adipose depots. Both plasma and hepatic Fgf21 levels are increased in Crtc2 liver-specific knockout mice, as a result of the reduced miR-34a expression regulated by Creb/Crtc2 and the induction of Sirt1 and Pparα. Ectopic expression of miR-34a reverses the metabolic changes in knockout liver. We suggest that Creb/Crtc2 negatively regulates the Sirt1/Pparα/Fgf21 axis via the induction of miR-34a under diet-induced obesity and insulin-resistant conditions.

摘要

肝脏在哺乳动物的能量平衡控制中起着至关重要的作用,尽管它影响其他外周组织的确切机制尚未得到解决。在这里,我们表明,Creb 调节转录共激活因子(Crtc)2 是全身能量代谢的主要调节剂。Crtc2 肝脏特异性敲除可降低血糖水平,并改善葡萄糖和胰岛素耐受性。肝脏特异性敲除小鼠表现出更高的能量消耗,脂肪组织中的脂肪滴更小。由于 Creb/Crtc2 调节的 miR-34a 表达减少和 Sirt1 和 Pparα 的诱导,血浆和肝 Fgf21 水平在 Crtc2 肝脏特异性敲除小鼠中增加。miR-34a 的异位表达逆转了敲除肝脏的代谢变化。我们认为,在饮食诱导的肥胖和胰岛素抵抗条件下,Creb/Crtc2 通过诱导 miR-34a 负调节 Sirt1/Pparα/Fgf21 轴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/91e4531d4ade/41467_2017_1878_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/ecf825877dbe/41467_2017_1878_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/262ab0547b03/41467_2017_1878_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/1271e3fd2b1e/41467_2017_1878_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/91e4531d4ade/41467_2017_1878_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/ecf825877dbe/41467_2017_1878_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/262ab0547b03/41467_2017_1878_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/1271e3fd2b1e/41467_2017_1878_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca2/5709393/91e4531d4ade/41467_2017_1878_Fig4_HTML.jpg

相似文献

1
Hepatic Crtc2 controls whole body energy metabolism via a miR-34a-Fgf21 axis.肝 Crtc2 通过 miR-34a-Fgf21 轴控制全身能量代谢。
Nat Commun. 2017 Nov 30;8(1):1878. doi: 10.1038/s41467-017-01878-6.
2
A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.CRTC2 在促进非酒精性脂肪性肝病中的新作用。
Mol Metab. 2022 Jan;55:101402. doi: 10.1016/j.molmet.2021.101402. Epub 2021 Nov 24.
3
Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.肝 SIRT1 通过诱导成纤维细胞生长因子 21 减轻小鼠肝脂肪变性并控制能量平衡。
Gastroenterology. 2014 Feb;146(2):539-49.e7. doi: 10.1053/j.gastro.2013.10.059. Epub 2013 Nov 1.
4
Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.富含肝的转录因子 CREBH 与过氧化物酶体增殖物激活受体 α 相互作用,调节代谢激素 FGF21。
Endocrinology. 2014 Mar;155(3):769-82. doi: 10.1210/en.2013-1490. Epub 2014 Jan 1.
5
CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.CREB 上调的长链非编码 RNA MEG3 通过调节 miR-302a-3p-CRTC2 轴促进肝糖异生。
J Cell Biochem. 2019 Mar;120(3):4192-4202. doi: 10.1002/jcb.27706. Epub 2018 Sep 27.
6
Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes. adiponectin 通过 PP2A/AMPK 通路调节胰岛素抵抗肝细胞的肝糖生成。
FASEB J. 2020 Aug;34(8):10056-10072. doi: 10.1096/fj.202000115RR. Epub 2020 Jun 24.
7
Role of CRTC2 in Metabolic Homeostasis: Key Regulator of Whole-Body Energy Metabolism?CRTC2 在代谢稳态中的作用:全身能量代谢的关键调节剂?
Diabetes Metab J. 2020 Aug;44(4):498-508. doi: 10.4093/dmj.2019.0200. Epub 2020 Mar 5.
8
Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.miR-34a通过靶向非酒精性脂肪性肝病中PPARα的表达来调节脂肪变性的作用。
Sci Rep. 2015 Sep 2;5:13729. doi: 10.1038/srep13729.
9
Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.肝 Sam68 调节全身葡萄糖稳态和胰岛素敏感性。
Int J Mol Sci. 2022 Sep 29;23(19):11469. doi: 10.3390/ijms231911469.
10
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.一种禁食诱导开关通过激活剂/共激活剂交换调节糖异生。
Nature. 2008 Nov 13;456(7219):269-73. doi: 10.1038/nature07349. Epub 2008 Oct 5.

引用本文的文献

1
From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH.从脂肪肝到肝纤维化:微小RNA对非酒精性脂肪性肝病和非酒精性脂肪性肝炎的影响。
Funct Integr Genomics. 2025 Jan 31;25(1):30. doi: 10.1007/s10142-025-01544-x.
2
Overexpression and biophysical and functional characterization of a recombinant FGF21.重组FGF21的过表达及其生物物理和功能特性分析
Biophys Rep (N Y). 2025 Mar 12;5(1):100198. doi: 10.1016/j.bpr.2025.100198. Epub 2025 Jan 29.
3
Effect of gene CRTC2 on the differentiation of subcutaneous precursor adipocytes in goats.

本文引用的文献

1
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue.成纤维细胞生长因子 21(FGF21)抵抗并非通过下调白色脂肪组织中β-klotho 的表达介导。
Mol Metab. 2017 Mar 27;6(6):602-610. doi: 10.1016/j.molmet.2017.03.009. eCollection 2017 Jun.
2
FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver.成纤维细胞生长因子21介导肝脏对单糖摄入和甜味偏好的内分泌控制。
Cell Metab. 2016 Feb 9;23(2):335-43. doi: 10.1016/j.cmet.2015.12.003. Epub 2015 Dec 24.
3
Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
基因CRTC2对山羊皮下前体脂肪细胞分化的影响。
Anim Biosci. 2025 May;38(5):873-883. doi: 10.5713/ab.24.0248. Epub 2024 Oct 28.
4
Exploring endocrine FGFs - structures, functions and biomedical applications.探索内分泌成纤维细胞生长因子——结构、功能及生物医学应用
Int J Biochem Mol Biol. 2024 Aug 25;15(4):68-99. doi: 10.62347/PALK2137. eCollection 2024.
5
Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues.探讨 2 型糖尿病中的组蛋白去乙酰化酶:病理生理学见解与治疗途径。
Clin Epigenetics. 2024 Jun 11;16(1):78. doi: 10.1186/s13148-024-01692-0.
6
Nuclear receptor corepressors non-canonically drive glucocorticoid receptor-dependent activation of hepatic gluconeogenesis.核受体辅阻遏物非经典地驱动肝糖异生中糖皮质激素受体依赖性的激活。
Nat Metab. 2024 May;6(5):825-836. doi: 10.1038/s42255-024-01029-4. Epub 2024 Apr 15.
7
Treatment of Obesity Through Glial Cell-Derived Neurotrophic Factor Lipid Nanoparticle Delivery in Mice.通过胶质细胞源性神经营养因子脂质纳米颗粒递送治疗小鼠肥胖症。
Gastro Hep Adv. 2024;3(1):38-47. doi: 10.1016/j.gastha.2023.08.012. Epub 2023 Aug 31.
8
Molecular and Metabolic Analysis of Arsenic-Exposed Humanized AS3MT Mice.砷暴露人源化 AS3MT 小鼠的分子和代谢分析。
Environ Health Perspect. 2023 Dec;131(12):127021. doi: 10.1289/EHP12785. Epub 2023 Dec 27.
9
Modulating glucocorticoid receptor actions in physiology and pathology: Insights from coregulators.调节糖皮质激素受体在生理和病理中的作用:共激活因子的见解。
Pharmacol Ther. 2023 Nov;251:108531. doi: 10.1016/j.pharmthera.2023.108531. Epub 2023 Sep 16.
10
MicroRNA regulation of AMPK in nonalcoholic fatty liver disease.微小 RNA 对非酒精性脂肪性肝病 AMPK 的调控作用。
Exp Mol Med. 2023 Sep;55(9):1974-1981. doi: 10.1038/s12276-023-01072-3. Epub 2023 Sep 1.
miR-34a通过靶向非酒精性脂肪性肝病中PPARα的表达来调节脂肪变性的作用。
Sci Rep. 2015 Sep 2;5:13729. doi: 10.1038/srep13729.
4
The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1.CREB 共激活因子 CRTC2 通过调节 SREBP1 控制肝脏脂质代谢。
Nature. 2015 Aug 13;524(7564):243-6. doi: 10.1038/nature14557. Epub 2015 Jul 6.
5
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.代谢激素FGF15/19和FGF21的组织特异性作用。
Trends Endocrinol Metab. 2015 Jan;26(1):22-9. doi: 10.1016/j.tem.2014.10.002. Epub 2014 Dec 1.
6
FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss.成纤维细胞生长因子21在中枢发挥作用,诱导交感神经活动、能量消耗和体重减轻。
Cell Metab. 2014 Oct 7;20(4):670-7. doi: 10.1016/j.cmet.2014.07.012. Epub 2014 Aug 14.
7
FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.FGF21 通过在长时间禁食期间介导肝脏和大脑之间的串扰来维持葡萄糖稳态。
Diabetes. 2014 Dec;63(12):4064-75. doi: 10.2337/db14-0541. Epub 2014 Jul 14.
8
SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo.SIK2 在体内脂质动态平衡和脂肪生成的调控中至关重要。
Diabetes. 2014 Nov;63(11):3659-73. doi: 10.2337/db13-1423. Epub 2014 Jun 4.
9
Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.肥胖症中升高的 microRNA-34a 通过直接靶向 NAMPT 降低 NAD+ 水平和 SIRT1 活性。
Aging Cell. 2013 Dec;12(6):1062-72. doi: 10.1111/acel.12135. Epub 2013 Aug 11.
10
Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine.自噬缺陷通过诱导成纤维生长因子 21(Fgf21)作为一种线粒体源细胞因子而防止肥胖和胰岛素抵抗。
Nat Med. 2013 Jan;19(1):83-92. doi: 10.1038/nm.3014. Epub 2012 Dec 2.